All trading involves risk. Losses can exceed deposits.

Clinigen ‘definitely not expecting a slowdown in H2’ as acquisitions are bedded in

3 March 2016: Clinigen deputy CEO Shaun Chilton, says it will remain a cash generating business and recent acquisitions will only serve to drive it forward. On the Brexit vote, Shaun says that Clinigen would be better served if the UK remained in.